Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by newdaydawningon Nov 22, 2020 4:26pm

862 Views

Post# 31949441

Let's not lose sight of the immediate prize

The NMBIC ph2 trial has been badly delayed by the pandemic, but the truly exciting news on vaccine front bodes well for commencement of procedures in US sites, possibly as early as Q2/21.

TLT's unmatched therapy for NMBIC will progress from fast-track to breakthrough over the next two years, returning huge gains for patient shareholders.

Let's never lose sight that TLD-1433 for NMBIC will be the key value driver for TLT for the foreseeable future.

<< Previous

Bullboard Posts

Next >>

Three stocks with strong income statements to buy right now